Market Overview
The Advanced Therapy Medicinal Products (ATMP) market is poised for significant growth, with projections indicating a rise from USD 9,805 million in 2024 to approximately USD 29,578.94 million by 2032. This growth represents a compound annual growth rate (CAGR) of 14.8% from 2024 to 2032. ATMPs, which include gene therapies, somatic-cell therapies, and tissue-engineered therapies, are revolutionizing the treatment of complex and rare diseases by offering innovative solutions for p